Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Tinnitus is the perception of sound in the absence of a corresponding external acoustic stimulus. With prevalence ranging from 10% to 15%, tinnitus is a common disorder. Many people habituate to the phantom sound, but tinnitus severely impairs quality of life of about 1–2% of all people. Tinnitus has traditionally been regarded as an otological disorder, but advances in neuroimaging methods and development of animal models have increasingly shifted the perspective towards its neuronal correlates. Most widely used treatments for tinnitus involve counselling, and best evidence is available for cognitive behavioral therapy. New pathophysiological insights have prompted the development of innovative brain-based treatment approaches to directly target the neuronal correlates of tinnitus.
The global tinnitus management market is observing significant growth owing to increasing population base for hearing impairment patients and rapidly growing elderly population. According to British Tinnitus Association, around 90% of the people with tinnitus have reported hearing loss. Many approaches for tinnitus management and treatment include medications, vitamin therapy, biofeedback, hypnosis, electrical stimulation, relaxation therapy, counselling, habituation therapies, tinnitus retraining therapy [TRT], cognitive behavioural therapy [CBT], tinnitus maskers and hearing aid. Counselling plays an important role in every type of tinnitus management such as TRT and CBT. Development of novel and innovative devices and therapies for tinnitus management would aid in market growth. For instance, mobile application-based music therapy aids in managing symptoms and effectively treat the condition through prescribed music listening experience for one to two hours a day for specific period.
The report analyses the global tinnitus management market based on product, indication, distribution channel and geography.
Based on product, the market is categorized into sound masking devices, hearing aids, notched music devices and cochlear implants. A cochlear implant is an electronic medical device that replaces the function of the damaged inner ear. Unlike hearing aids, which make sounds louder, cochlear implants bypass the damaged hair cells of the inner ear (cochlea) to provide sound signals to the brain.
The indications of tinnitus management market are subjective tinnitus and objective tinnitus. Subjective tinnitus is perception of sound in the absence of an acoustic stimulus and is heard only by the patient. Most tinnitus is subjective. Objective tinnitus is uncommon and results from noise generated by structures near the ear.
Furthermore, various distribution channels of this market are categorized into audiology centres, ENT Clinics, hospitals and e-commerce. Tinnitus management products are offered at various hospitals and ENT clinics, Moreover, several therapies are available in the market that help to suppress tinnitus. These include medical counselling, cognitive behavioral therapy (CBT), tinnitus retraining therapy (TRT), and sound therapy.
By geography, the global tinnitus management market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world. In 2018, North America held the largest revenue share mainly due to factors such as government support for quality healthcare, high purchasing power parity, availability of reimbursement, and increasing prevalence of tinnitus in U.S. and Canada. Furthermore, Asia Pacific is expected to witness lucrative growth over the forecast period owing to supportive government initiatives and improving healthcare infrastructure. Additionally, economic developments in countries, such as India and China, are expected to help spur the market growth. Huge population base with low per capita income in the region led to high demand for affordable treatment options.
The leading tinnitus management market players are Cochlear Americas, Inc., GN Hearing A/S, Neuromod Devices Ltd., Neuromonics, Inc., Oticon Inc., Auris Medical Holding AG, Puretone Ltd., Sivantos, Inc., Starkey Hearing Technologies, Inc. and Widex A/S. These companies have adopted various strategies, such as new product launches, collaborations, technological advancements, M&A, to sustain their position in the market. For instance, in January 2018, Oticon launched its ConnectClip, which is a connectivity device that turns hearing aids into wireless headset for improving user’s listening and communication experience.
Several companies such as Oticon Inc. and GN Hearing/S have launched their mobile applications that produces sound to mask the tinnitus sound in subjective tinnitus patients. Auris Medical Holding AG is focusing on developing novel molecule, Keyzilen, for the treatment of acute inner ear tinnitus following traumatic cochlear injury or otitis media. Keyzilen contains Esketamine hydrochloride—a biocompatible and fully biodegradable—which is an N-Methyl-D-Aspartate receptor antagonist.
The global tinnitus management market is segmented based on product, indication, distribution channel and geography. Based on product, the market is categorized into sound masking devices, hearing aids, notched music devices and cochlear implants. A cochlear implant is an electronic medical device that replaces the function of the damaged inner ear.
The indications of tinnitus management market are subjective tinnitus and objective tinnitus. Subjective tinnitus is perception of sound in the absence of an acoustic stimulus and is heard only by the patient. Most tinnitus is subjective.
Furthermore, various distribution channels of this market are categorized into audiology centres, ENT Clinics, hospitals and e-commerce. Tinnitus management products are offered at various hospitals and ENT clinics, Moreover, several therapies are available in the market that help to suppress tinnitus.
By geography, the global tinnitus management market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world. In 2018, North America held the largest revenue share mainly due to factors such as government support for quality healthcare, high purchasing power parity, availability of reimbursement, and increasing prevalence of tinnitus in U.S. and Canada.
Why to buy this report:
